Anthem Biosciences IPO allotment status online check can be done through the websites of BSE and NSE, along with the official ...

Anthem Biosciences IPO allotment status is finalised and investors now shift focus towards the Anthem Biosciences IPO listing ...

Inhibrx Biosciences rises on early clinical success; Ozekibart shows promise in colorectal cancer. Read here for an analysis ...

Anthem Biosciences IPO oversubscribed, set to list with 20-25% gain, raising ₹1,016 crore from anchor investors.

Anthem Biosciences IPO Allotment: The IPO of Anthem Biosciences is now heading toward its next big step and that is ‘share ...

Once the Anthem Biosciences IPO allotment is finalised, investors can check their status on the official websites of BSE, NSE ...

This strong response from different investor categories highlights the market's confidence in ABL's potential as a publicly ...

The Anthem Biosciences IPO bidding window was open from July 14 to July 16, 2025. The share allotment is expected to be ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Caribou Biosciences' allogeneic CAR T-cell therapies show promising early efficacy and safety, but require clinical ...

Investors who bid for the issue can check the share allotment status on the websites of BSE, NSE and KFin Technologies by ...

The issue was oversubscribed 63.86 times overall, with the retail investor portion subscribed 5.64 times and the ...